Literature DB >> 25247515

Implementing lung cancer screening under Medicare: the last chance to get it right?

Harold C Sox1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25247515     DOI: 10.1001/jama.2014.12921

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.

Authors:  Tanner J Caverly; Pianpian Cao; Rodney A Hayward; Rafael Meza
Journal:  Ann Intern Med       Date:  2018-05-29       Impact factor: 25.391

Review 2.  Update in Lung Cancer 2014.

Authors:  Avrum Spira; Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

Review 3.  Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Douglas E Wood; Ella A Kazerooni; Scott L Baum; George A Eapen; David S Ettinger; Lifang Hou; David M Jackman; Donald Klippenstein; Rohit Kumar; Rudy P Lackner; Lorriana E Leard; Inga T Lennes; Ann N C Leung; Samir S Makani; Pierre P Massion; Peter Mazzone; Robert E Merritt; Bryan F Meyers; David E Midthun; Sudhakar Pipavath; Christie Pratt; Chakravarthy Reddy; Mary E Reid; Arnold J Rotter; Peter B Sachs; Matthew B Schabath; Mark L Schiebler; Betty C Tong; William D Travis; Benjamin Wei; Stephen C Yang; Kristina M Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2018-04       Impact factor: 11.908

Review 4.  Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.

Authors:  Anne M Joseph; Alexander J Rothman; Daniel Almirall; Abbie Begnaud; Caroline Chiles; Paul M Cinciripini; Steven S Fu; Amanda L Graham; Bruce R Lindgren; Anne C Melzer; Jamie S Ostroff; Elizabeth L Seaman; Kathryn L Taylor; Benjamin A Toll; Steven B Zeliadt; David M Vock
Journal:  Am J Respir Crit Care Med       Date:  2018-01-15       Impact factor: 30.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.